国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli LPS-assembly protein lptD (lptD) CSB-YP327058ENV
CSB-EP327058ENV
CSB-BP327058ENV
CSB-MP327058ENV
CSB-EP327058ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Crotonobetainyl-CoA:carnitine CoA-transferase (caiB) CSB-YP327060ENV
CSB-EP327060ENV
CSB-BP327060ENV
CSB-MP327060ENV
CSB-EP327060ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Type II secretion system protein G (outG) CSB-YP327061ESP
CSB-EP327061ESP
CSB-BP327061ESP
CSB-MP327061ESP
CSB-EP327061ESP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glutamine synthetase 3 (glnT) CSB-YP327062RKO
CSB-EP327062RKO
CSB-BP327062RKO
CSB-MP327062RKO
CSB-EP327062RKO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrate-sodium symporter (citP), partial CSB-YP327063SWM
CSB-EP327063SWM
CSB-BP327063SWM
CSB-MP327063SWM
CSB-EP327063SWM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wound tumor virus Protein P7, partial CSB-YP327064WBB
CSB-EP327064WBB
CSB-BP327064WBB
CSB-MP327064WBB
CSB-EP327064WBB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Murine coronavirus Hemagglutinin-esterase (HE), partial CSB-YP327065MKB1
CSB-EP327065MKB1
CSB-BP327065MKB1
CSB-MP327065MKB1
CSB-EP327065MKB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sheep pulmonary adenomatosis virus Protein Vpu (vpu) CSB-YP327066SFU
CSB-EP327066SFU
CSB-BP327066SFU
CSB-MP327066SFU
CSB-EP327066SFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Pantothenate synthetase (panC) CSB-YP327067ENV
CSB-EP327067ENV
CSB-BP327067ENV
CSB-MP327067ENV
CSB-EP327067ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica 17.4 kDa class I heat shock protein (HSP17.4) CSB-YP327068OFG
CSB-EP327068OFG
CSB-BP327068OFG
CSB-MP327068OFG
CSB-EP327068OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative metabolite transport protein yaaU (yaaU), partial CSB-YP327069ENV
CSB-EP327069ENV
CSB-BP327069ENV
CSB-MP327069ENV
CSB-EP327069ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solanum tuberosum 4-coumarate--CoA ligase 1 (4CL1), partial CSB-YP327070FIG
CSB-EP327070FIG
CSB-BP327070FIG
CSB-MP327070FIG
CSB-EP327070FIG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Type II secretion system protein C (outC), partial CSB-YP327071ESP
CSB-EP327071ESP
CSB-BP327071ESP
CSB-MP327071ESP
CSB-EP327071ESP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum Type II secretion system protein E (outE) CSB-YP327072ESP
CSB-EP327072ESP
CSB-BP327072ESP
CSB-MP327072ESP
CSB-EP327072ESP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Type 4 prepilin-like proteins leader peptide-processing enzyme (outO), partial CSB-YP327073EGI1
CSB-EP327073EGI1
CSB-BP327073EGI1
CSB-MP327073EGI1
CSB-EP327073EGI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays Cystatin-1 (RAMDAZC7) CSB-YP327074ZAX
CSB-EP327074ZAX
CSB-BP327074ZAX
CSB-MP327074ZAX
CSB-EP327074ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xanthomonas campestris pv. campestris Type II secretion system protein I (xpsI) CSB-YP327075XAY
CSB-EP327075XAY
CSB-BP327075XAY
CSB-MP327075XAY
CSB-EP327075XAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus sp. Cyclomaltodextrin glucanotransferase (cgt), partial CSB-YP327076BBN
CSB-EP327076BBN
CSB-BP327076BBN
CSB-MP327076BBN
CSB-EP327076BBN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein-glutamate methylesterase FrzG (frzG) CSB-YP327077MXA
CSB-EP327077MXA
CSB-BP327077MXA
CSB-MP327077MXA
CSB-EP327077MXA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Fe/S biogenesis protein NfuA (nfuA) CSB-YP327078HTA
CSB-EP327078HTA
CSB-BP327078HTA
CSB-MP327078HTA
CSB-EP327078HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>